You Own Wall Street › Funds › Eaton Vance Worldwide Health Sciences Fund

Eaton Vance Worldwide Health Sciences Fund (ETHSX) proxy voting record 2026

Three of its ballots from this season. Vote first, then see what it did with the shares your savings paid for.

The question on the ballot

As filed

Eaton Vance Growth Trust files this fund's proxy votes with the SEC once a year. This is what it did with the shares your retirement savings paid for.

SourceProxy-voting record filed by Eaton Vance Growth Trust on 2026-08-03 · open the filing · vote table (ProxyVotingTable.xml, 8.4 MB)

TickersETHSX, ECHSX, ERHSX, EIHSX · share classes of one fund, with one proxy-voting record · as listed in its latest SEC filing of proxy votes

How it voted, by issue

Fund companies sometimes file the same proposal under different subjects. So that funds can be compared, each proposal is counted under the subject most of the filings we read gave it, the same for every fund on this site. On management's own executive pay resolutions, this fund voted in favour 93.8% of the time across 32 votes.

IssueProposals facedBackedShare backed
Climate & environment300%
Corporate governance10550%
Other social issues3133.3%

Ballots it voted

Merck & Co., Inc. · 26 May 2026 · put on the ballot by shareholder · Climate & environment

Regarding a report on DEI risks in federal contracting.

AGAINST  Eaton Vance Worldwide Health Sciences Fund voted with 307,185 shares

“Shareholder proposal regarding a report on DEI risks in federal contracting.”

SourceEaton Vance Growth Trust, Form N-PX filed 2026-08-03 · accession 0001140361-26-030849 · series S000005202 · open the filing

Merck & Co., Inc. · 26 May 2026 · put on the ballot by shareholder · Climate & environment

Regarding a report on healthcare coverage gaps.

AGAINST  Eaton Vance Worldwide Health Sciences Fund voted with 307,185 shares

“Shareholder proposal regarding a report on healthcare coverage gaps.”

SourceEaton Vance Growth Trust, Form N-PX filed 2026-08-03 · accession 0001140361-26-030849 · series S000005202 · open the filing

Bristol-Myers Squibb Company · 5 May 2026 · put on the ballot by shareholder

On the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director

AGAINST  Eaton Vance Worldwide Health Sciences Fund voted with 563,654 shares

“Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director”

SourceEaton Vance Growth Trust, Form N-PX filed 2026-08-03 · accession 0001140361-26-030849 · series S000005202 · open the filing

AbbVie Inc. · 8 May 2026 · put on the ballot by shareholder

Should the person who runs AbbVie also chair the board that supervises them?

Shareholders asked the company to require that the chair of the board be an independent director rather than the chief executive, so that the body overseeing management is not led by the person being overseen.

AGAINST  Eaton Vance Worldwide Health Sciences Fund voted with 238,538 shares

“Stockholder Proposal - to Adopt a Policy to Require an Independent Chair”

SourceEaton Vance Growth Trust, Form N-PX filed 2026-08-03 · accession 0001140361-26-030849 · series S000005202 · open the filing

Merck & Co., Inc. · 26 May 2026 · put on the ballot by shareholder · Social

Should Merck disclose the politics its money pays for?

Shareholders asked the company to publish its political spending — direct contributions and money routed through trade associations and other third parties — and whether that spending matches the values the company states publicly.

AGAINST  Eaton Vance Worldwide Health Sciences Fund voted with 307,185 shares

“Shareholder proposal regarding a report on political contributions.”

SourceEaton Vance Growth Trust, Form N-PX filed 2026-08-03 · accession 0001140361-26-030849 · series S000005202 · open the filing

Eli Lilly and Company · 4 May 2026 · put on the ballot by shareholder · Social

Should Eli Lilly and disclose what it lobbies for?

Shareholders asked for a report on the company’s lobbying: what it spends, which trade associations receive its money, what positions those bodies take, and who inside the company decides.

FOR  Eaton Vance Worldwide Health Sciences Fund voted with 93,351 shares

“Shareholder proposal to prepare an annual lobbying report.”

SourceEaton Vance Growth Trust, Form N-PX filed 2026-08-03 · accession 0001140361-26-030849 · series S000005202 · open the filing

Other funds Eaton Vance Growth Trust votes

The same filer reports these alongside this one, in the same annual filing.

Eaton Vance All Asset Strategy Fund86.1% for exec payEaton Vance Atlanta Capital Focused Growth Fund81.3% for exec payEaton Vance Atlanta Capital Select Equity Fund80% for exec payEaton Vance Atlanta Capital SMID-Cap Fund97.7% for exec payEaton Vance China Equity FundEaton Vance Equity Strategy Fund86.4% for exec payEaton Vance Focused Growth Opportunities Fund92% for exec payEaton Vance Focused Value Opportunities Fund91.7% for exec payEaton Vance International Small-Cap Fund81.4% for exec pay

No 401(k) plan we index offers this fund. Its record is here because the fund files it with the SEC, as every fund must: whoever holds it, in an IRA, a brokerage account or a plan we have not indexed, the fund votes those shares as shown on this page.

More funds no plan we index offers, and how each voted →